ESC 365 - Doctor So-Ryoung Lee

Speaker illustration

Doctor So-Ryoung Lee

Seoul National University Hospital, Seoul (Korea (Republic of))

Mar 2008 - Feb 2009 Internship, Seoul National University Hospital, Seoul, Korea Mar 2009 - Feb 2013 Residency in Internal Medicine, Seoul National University Hospital, Seoul, Korea Mar 2014 - Feb 2017 Fellowship in Division of Cardiology (including Electrophysiology fellowship), Seoul National University Hospital, Seoul, Korea Mar 2017 – Present Assistant professor, Internal Medicine, Soon Chun Hyang University Hospital, Seoul, Korea

Risk of atrial fibrillation in young adults aged 20 to 39 years with isolated diastolic, isolated systolic, and systolic-diastolic hypertension: a nationwide population-based study

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation: the role of risk markers

Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study

Event: ESC Congress 2021 - The Digital Experience

Topic: Lifestyle Modification

Session: Atrial fibrillation: risks and management

Clustering of healthy lifestyle behaviors is associated with a lower incidence of adverse events in patients with newly diagnosed atrial fibrillation: a nationwide cohort study

Event: ESC Congress 2021 - The Digital Experience

Topic: Lifestyle Modification

Session: Arrhythmias e-posters

Antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease of 1-year and 3-year after percutaneous coronary intervention: a nationwide population-based study

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Net clinical benefit of direct oral anticoagulants in very elderly and high bleeding risk patients with atrial fibrillation who are often excluded from oral anticoagulation therapy: a nationwide popul

Event: ESC Congress 2021 - The Digital Experience

Topic: Anticoagulants

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Management and clinical outcome of patients with atrial fibrillation stratified by the 4S-AF scheme for structured characterization of atrial fibrillation: data from CODE-AF registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation e-posters

Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation

Event: EHRA 2021

Topic: Oral Anticoagulation

Session: Prevention of stroke in atrial fibrillation

Hypertension burden and the risk of new-onset atrial fibrillation: a nationwide population-based study

Event: EHRA 2021

Topic: Arrhythmias

Session: Arrhythmias in congenital heart diseases and more

Comparison between non-vitamin K antagonist oral anticoagulants versus warfarin for the risk of dementia in Asian patients with non-valvular atrial fibrillation

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cognitive Function and Autonomy in Patients with Atrial Fibrillation

Session: NOAC Dosing, Adherence and Treatment Effects

Association between left atrial wall thickness and residual potential after pulmonary vein antral isolation in patients with atrial fibrillation receiving Ablation Index-guided ablation

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation ePosters

This platform is supported by